alopecia universalis
Information
- Disease name
- alopecia universalis
- Disease ID
- DOID:0050634
- Description
- "An alopecia characterized by the complete loss of hair on the scalp and body." [url:https\://rarediseases.info.nih.gov/diseases/614/alopecia-universalis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00069589 | Active, not recruiting | Alopecia Areata Registry | November 2001 | November 2099 | |
| NCT05098600 | Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic | October 15, 2021 | December 20, 2022 | |
| NCT02312882 | Completed | N/A | Tofacitinib for the Treatment of Alopecia Areata and Its Variants | December 2014 | August 2015 |
| NCT02812342 | Completed | Phase 2 | Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants | September 2016 | December 2018 |
| NCT03551821 | Completed | Phase 2 | Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata | April 11, 2018 | November 6, 2018 |
| NCT06278402 | Completed | Phase 3 | Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi. | July 1, 2023 | January 16, 2024 |
| NCT05589610 | Completed | Phase 2 | Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata | December 19, 2022 | April 30, 2024 |
| NCT01167946 | Completed | Phase 4 | Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata | January 2003 | July 2010 |
| NCT06283316 | Recruiting | Systemic Treatments for Alopecia Areata Registry | January 17, 2024 | December 31, 2099 | |
| NCT04011748 | Recruiting | Phase 2 | Clinical Application of Stem Cell Educator Therapy in Alopecia Areata | September 20, 2022 | July 30, 2023 |
| NCT03759340 | Terminated | Phase 2 | ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) | January 15, 2019 | September 11, 2019 |
| NCT04238091 | Withdrawn | Phase 2 | Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata | December 19, 2019 | March 2, 2022 |
| NCT03532958 | Withdrawn | Phase 2 | Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata | October 2021 | November 2022 |
- Disase is a (Disease Ontology)
- DOID:987
- Cross Reference ID (Disease Ontology)
- GARD:614
- Cross Reference ID (Disease Ontology)
- MESH:C537055
- Cross Reference ID (Disease Ontology)
- MIM:203655
- Exact Synonym (Disease Ontology)
- ALOPECIA UNIVERSALIS CONGENITA
- HPO alt_id (Human Phenotype Ontology)
- HP:0004550
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002289
- OrphaNumber from OrphaNet (Orphanet)
- 701
- ICD10 preferred id (Insert disease from ICD10)
- D0009860
- ICD10 class code (Insert disease from ICD10)
- L63.1